Main Page

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 45: Line 45:
<td style="padding: 10px;>
<td style="padding: 10px;>
-
<p>[[I3DC|About Interactive 3D Complement]]</p>
+
<p>[[I3DC|About Interactive 3D Complements ('''I3DCs''')]]</p>
-
<p>[[Proteopedia:I3DC|List of Interactive 3D Complements('''I3DCs''')]]</p>
+
<p>[[Proteopedia:I3DC|List of I3DCs]]</p>
-
<p>[[How to get an I3DC for your paper]]</p>
+
<p>[[How to get an I3DC for your paper]]</p>
</td>
</td>

Revision as of 09:53, 21 October 2018

ISSN 2310-6301

As life is more than 2D, Proteopedia helps to bridge the 3D relationships between function & structure of biomacromolecules


Selected Pages Art on Science Journals Education
About this image
Coronavirus Spike Protein Priming

by Eric Martz
Coronavirus SARS-CoV-2 (responsible for COVID-19) has a spike protein on its surface, which enables it to infect host cells. Initially, proteases in the lungs clip the homo-trimeric spike protein at a unique sequence. This primes it, causing it to extend its receptor binding surface (shown in the above animation), optimizing binding to the host cell's ACE2 receptor (not shown). Next, spike protein initiates fusion of the virus and host cell membranes (not shown), enabling the virus RNA to enter the cell and initiate production of new virions. Knowledge of spike protein's molecular structure and function is crucial to developing effective therapies and vaccines.
>>> Visit this page >>>

About this image
Molecular Sculpture

by Eric Martz
A historical review on sculptures and physical models of macromolecules.

>>> Visit this page >>>

About this image
Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases.

IB Tomasic, MC Metcalf, AI Guce, NE Clark, SC Garman. J. Biol. Chem. 2010 doi: 10.1074/jbc.M110.118588
The human lysosomal enzymes α-galactosidase and α-N-acetylgalactosaminidase share 46% amino acid sequence identity and have similar folds. Using a rational protein engineering approach, we interconverted the enzymatic specificity of α-GAL and α-NAGAL. The engineered α-GAL retains the antigenicity but has acquired the enzymatic specificity of α-NAGAL. Conversely, the engineered α-NAGAL retains the antigenicity but has acquired the enzymatic specificity of the α-GAL enzyme. Comparison of the crystal structures of the designed enzyme to the wild-type enzymes shows that active sites superimpose well, indicating success of the rational design. The designed enzymes might be useful as non-immunogenic alternatives in enzyme replacement therapy for treatment of lysosomal storage disorders such as Fabry disease.

>>> Visit this I3DC complement >>>

About this image
You Are What You Eat!

Above is an integral membrane protein that takes up, into your intestinal cells, orally consumed peptide nutrients and drugs. Its lumen-face (top) opens and binds peptide or drug (small solid object in the center), then closes, while its cytoplasmic face (bottom) opens to release its cargo into the intestinal cell, which passes it on to the blood circulation.

>>> See more animations and explanation >>>

How to add content to Proteopedia

Video Guides

Who knows ...

List of Art on Science pages in Proteopedia

About Interactive 3D Complements (I3DCs)

List of I3DCs

How to get an I3DC for your paper

Teaching Strategies Using Proteopedia

Examples of Pages for Teaching

How to add content to Proteopedia

About Contact Table of Contents Structure Index Help

Proteopedia Page Contributors and Editors (what is this?)

Joel L. Sussman, Jaime Prilusky

Personal tools